{
  "pmcid": "10997180",
  "sha256": "427c8a77bdf1c89f2045001069d4af989be6772858da61efcd0a9bf96a3e5a63",
  "timestamp_utc": "2025-11-09T21:58:51.516270+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.284761904761904,
    "reading_ease": 21.98246031746035,
    "word_count": 224
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Sacral Neuromodulation vs. Personalized Conservative Treatment for Refractory Idiopathic Slow-Transit Constipation: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomised in a 3:2 ratio to SNM (n=41) or personalized conservative treatment (PCT, n=26) using web-based minimization."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants aged 14-80 years with idiopathic STC, defecation frequency <3 per week, and refractory to maximal conservative treatment were included."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised in a 3:2 ratio to SNM (n=41) or personalized conservative treatment (PCT, n=26)."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was treatment success, defined as an average defecation frequency ≥3 per week, measured at 6 months."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "using web-based minimization"
      },
      "Blinding": {
        "score": 0,
        "evidence": "open-label"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Participants were randomised in a 3:2 ratio to SNM (n=41) or personalized conservative treatment (PCT, n=26)."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted on an intention-to-treat basis."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "At 6 months, 22 of 41 (53.7%) SNM patients achieved treatment success compared to 1 of 26 (3.8%) PCT patients (odds ratio 36.4, 95% CI 3.4–387.5, P=0.003)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were reported in 32 SNM and 8 PCT patients, with 6 serious events in SNM and 2 in PCT."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: ClinicalTrials.gov NCT02961582."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 17,
    "max_score": 25
  }
}